MEFV mutations in Turkish patients suffering from Familial Mediterranean Fever

N Akar1, M Misiroglu, F Yalcinkaya

  • 1Pediatric Molecular Pathology and Nephrology Departments, Ankara University, Ankara, Turkey.

Human Mutation
|December 29, 1999
PubMed

Insights

Familial Mediterranean fever (FMF) in Turkey is genetically diverse, with common mutations like M694V being prevalent. Molecular diagnosis is feasible, aiding in understanding FMF origins and associated amyloidosis.

Area of Science:

  • Genetics
  • Molecular Biology
  • Internal Medicine

Background:

  • Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory disorder.
  • FMF primarily affects populations including Sephardic Jews, Arabs, Armenians, and Turks.
  • The gene responsible for FMF, MEFV, has been identified, with several disease-associated mutations described.

Purpose of the Study:

  • To evaluate the frequency of seven MEFV mutations in Turkish FMF patients.
  • To determine the contribution of common and rare mutations to FMF in Turkey.
  • To investigate the association between specific MEFV mutations and amyloidosis in FMF patients.

Main Methods:

  • Analysis of 460 chromosomes from 230 unrelated Turkish FMF patients.
  • Utilized Polymerase Chain Reaction (PCR) methods to detect MEFV mutations.
  • Evaluated seven specific MEFV mutations: M694V, M680I, V726A, M694I, R761H, K695R, and E148Q.

Main Results:

  • The M694V allele was the most frequent (43.5%), with 19.1% of patients being homozygous.
  • M680I and V726A were also common, accounting for 12.0% and 11.1% of patients, respectively.
  • Three common mutations (M694V, M680V, V726A) accounted for two-thirds of disease alleles, and 79.6% of patients carried at least one main mutation.
  • Amyloidosis was observed in 28 patients, with M694V being the most common mutation among them.
  • Overall, 84.3% of patients carried at least one of the seven studied mutations.

Conclusions:

  • The genetic origin of FMF in Turkey is heterogeneous, with a significant contribution from multiple MEFV mutations.
  • Common FMF mutations are associated with the development of amyloidosis.
  • Rapid and accurate molecular diagnosis of FMF is achievable in the majority of Turkish patients.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...
Translation01:37

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.Translation Produces the Building Blocks of LifeProteins are called the...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Mutations in Microorganisms01:18

Mutations in Microorganisms

Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...